Savarese, Teresa
Abate, Andrea
Basnet, Ram Manohar
Lorini, Luigi
Gurizzan, Cristina
Tomasoni, Michele
Lombardi, Davide
Tomasini, Davide
Zizioli, Daniela
Memo, Maurizio
Berruti, Alfredo
Bonini, Sara A.
Sigala, Sandra
Bossi, Paolo
Funding for this research was provided by:
local grant of the University of Brescia
Article History
Received: 7 January 2022
Accepted: 2 June 2022
First Online: 15 June 2022
Competing interests
: Paolo Bossi: Advisory board or conference honoraria: Merck, Sanofi, Merck Sharp & Dohme, Sun Pharma, Angelini, Molteni, Bristol-Myers Squibb, Helsinn, GSK. All other authors declare no competing interests in the area of adenoid cystic carcinoma.